A key thrust of the business activity of Apex Healthcare Berhad is to grow international markets for its products and service and this commenced with exports of Xepa^sp products as early as the 1970s.

The Group now exports to some 12 countries worldwide and has established a Representative Office in Ho Chi Minh City, Vietnam in 2009. Plans are underway to grow international operations, with more representative offices planned for countries in Asia.

Besides international business, the Group has been actively investing in pharmaceutical ventures in the region. To date, the two key investments are in Apex Pharma Marketing Pte Ltd and PT Penta Valent in Indonesia.

Acquired in 2005, Apex Pharma Marketing Pte Ltd is a Singapore distributor of pharmaceuticals and consumer healthcare products.

http://www.apexpharmacy.com.sg/

Penta Valent was established in September 1968. Penta Valent is a distributor of pharmaceutical, medical and consumer health / cosmetic products in Indonesia with 33 branches providing service countrywide. Pharmaceuticals are supplied to over 11,000 dispensaries, 1,900 drugstores and 1,200 hospitals, and consumer health/ cosmetic products to over 20,000 outlets. Annual sales are over RM 275 million.

In 2007, Apex Healthcare Bhd acquired a 20% interest in Maritzberg Investment Limited which in turn holds 95% interest in PT Penta Valent, giving potential access to the Indonesian market for Apex Group's products. The two parties have already been able to draw upon a combined 8 decades of successful experience in distribution and wholesale, to significant mutual advantage.

Apex is pleased to have found a local partner in Indonesia with business values very compatible with Apex's own ethos of Service, Integrity and Quality.

 http://www.pentavalent.co.id/